Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FuFangYuXingCaoHeJi for sore throat with wind-heat syndrome
ChiCTR2100053105Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Nov 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of compound houttuynia mixture in acute pharyngitis and acute tonsillitis (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Rate of disappearance of sore throat. Started Nov 2021; status: recruiting.
02
Drugs
compound houttuynia mixture
03
Conditions
acute pharyngitisacute tonsillitis
Beyond the preview
Go deeper on ChiCTR2100053105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053105.